We have evaluated long-term retention rate of anakinra in adult onset Still disease and predictive factors for treatment response. The risk of losing anakinra efficacy increases along with the number of swollen joints at the start of therapy, while the typical skin rash is a negative predictor of anakinra withdrawal.
|Numero di pagine||2|
|Rivista||PEDIATRIC RHEUMATOLOGY ONLINE JOURNAL|
|Volume||10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)|
|Stato di pubblicazione||Pubblicato - 2019|